The pharmaceutical industry is defined as the discovery, development, and manufacture of drugs and medications. It’s widespread, including research, chemicals, and the regulation and involvement of government agencies. However, the characteristics of the pharmaceutical industry differ by region. Today, we’ll look at the key aspects of this sprawling industry in Europe, Africa, Latin America, and the United States.
globalEDGE Blog - By Tag: pharmaceuticals-industry
It is no secret that the new President of the United States, Donald Trump, favors protectionist economic policies. We are most used to hearing how his policies might affect relationships with China, Mexico, and Russia, but almost all countries will be impacted by the new president's policies. One of the countries who might see significant economic change from Trump's economy is India. India’s largest export, IT Services, face a particularly concentrated threat, and other industries such as pharmaceuticals also find themselves impacted by Trump’s America first policies.
Valeant Pharmaceuticals International Inc., a corporation based in Quebec, is currently in talks to sell Salix Pharmaceuticals Ltd., a company that manufactures gastrointestinal drugs. Valeant originally acquired Salix in March 2015 for $14.5 billion. The purchase was part of a growth strategy of buying pharmaceutical businesses with reputable products and cutting their research costs to maximize profits. However, Valeant lost much stock value over the past year due to unethical business activities, including price hikes, unreliable accounting, and secret collusion. Recently, the company undertook major efforts to change its leadership, settle its legal suits, pay off its debts, and re-establish growth. Selling Salix could be instrumental to these plans; just this week, news of the potential sale increased Valeant's stock by 34%. While prospective clients have been mostly kept anonymous, Japan's Takeda Phamaceutical Co. Ltd. has expressed public interest.